Cite
HARVARD Citation
Oudard, S. et al. (2016). Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma—Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study. European journal of cancer. pp. 28-35. [Online].